Clinical Trial Update: A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B

View source ↗

Summary

This clinical trial to assess the effectiveness and safety of neuraminidase inhibitors for long-term prophylaxis against pandemic influenza has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pandemic Influenza

Snippet

Sponsor: Kirby Institute | Conditions: Pandemic Influenza | Status: WITHDRAWN